News
Many investments Mr. Trump claims credit for predate his return to office or are based on vague future pledges. Here's a fact ...
Fremanezumab reduced migraine attacks and depression symptoms in migraine patients with major depressive disorder.
Shares of Eli Lilly (NYSE: LLY) sank after the drugmaker lowered its full-year profit outlook, and a potential headwind to ...
4h
WISH-TV on MSNLilly breaks ground on $4.5 billion R&D facilityEli Lilly officials and Gov. Mike Braun break ground on the LEAP District's Lilly Medicine Foundry, a $4.5 billion project ...
Zepbound is the preferred weight loss medicine vs. Wegovy and has consistently beaten the latter in U.S. weekly prescriptions ...
A former Boone County bean field is where Lilly will research, develop, and manufacture the medicines of the future. Company ...
Eli Lilly and Company became the first tenant to move into Lebanon’s LEAP district during a groundbreaking ceremony on ...
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of ...
WRTV Indianapolis, IN on MSN5h
"It's not backwoods country anymore": Eli Lilly breaks ground on $4.5 billion medicine foundry in Lebanon"It's not backwoods country anymore": Eli Lilly breaks ground on $4.5 billion medicine foundry in Lebanon ...
Eli Lilly and Co. will break ground on its $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana's LEAP Research and ...
Under terms of the deal, Alchemab will lead early Phase I trials for ATLX-1282 in amyotrophic lateral sclerosis, while Lilly ...
12h
Pharmaceutical Technology on MSNEli Lilly signs $415m deal for Alchemab’s ALS therapyThe deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results